These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 6172610

  • 1. Experimental allergic encephalomyelitis: suppression with SD-170, a new synthetic drug.
    Kasckow JW, Tabira T, Itoyama Y, Kuroiwa Y, Takenaka A, Nagai Y.
    Jpn J Exp Med; 1981 Oct; 51(5):293-8. PubMed ID: 6172610
    [Abstract] [Full Text] [Related]

  • 2. Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides.
    Raziuddin S, Morrison DC.
    J Immunol; 1982 Mar; 128(3):1486-9. PubMed ID: 6173441
    [Abstract] [Full Text] [Related]

  • 3. Influence of tetramisole on the induction of experimental allergic encephalomyelitis (EAE).
    Todorov DM, Michailov WG, Drumtcheva MA.
    Allerg Immunol (Leipz); 1982 Mar; 28(3):192-6. PubMed ID: 6183965
    [Abstract] [Full Text] [Related]

  • 4. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA, Nakafusa Y, Roland CR, Hickey WF, Flye MW.
    J Immunol; 1994 Nov 01; 153(9):3890-8. PubMed ID: 7523508
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB, Schluesener HJ.
    Arch Immunol Ther Exp (Warsz); 2006 Nov 01; 54(1):51-3. PubMed ID: 16642257
    [Abstract] [Full Text] [Related]

  • 6. Treatment of experimental allergic encephalomyelitis in rabbits with alpha-fetoprotein.
    Brenner T, Evron S, Soffer D, Abramsky O.
    Isr J Med Sci; 1985 Dec 01; 21(12):945-9. PubMed ID: 2419277
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic activity of malononitrilamides (MNA 279 and MNA 715) on acute and chronic, relapsing, experimental, allergic encephalomyelitis (EAE).
    Schorlemmer HU, Bartlett RR.
    Drugs Exp Clin Res; 1997 Dec 01; 23(5-6):175-81. PubMed ID: 9515227
    [Abstract] [Full Text] [Related]

  • 8. Cellular and humoral immune response to MBP during the course of chronic relapsing EAE.
    Schwerer B, Schuller-Levis GB, Mehta PD, Madrid RE, Wisniewski HM.
    Prog Clin Biol Res; 1984 Dec 01; 146():187-92. PubMed ID: 6201889
    [No Abstract] [Full Text] [Related]

  • 9. Humoral immune response in chronic relapsing experimental allergic encephalomyelitis (r-EAE) in guinea pigs.
    Olsson T, Henriksson A, Link H, Kristensson K.
    Prog Clin Biol Res; 1984 Dec 01; 146():179-86. PubMed ID: 6201888
    [No Abstract] [Full Text] [Related]

  • 10. Serum IgM repertoire reactions to MBP/CFA immunization reflect the individual status of EAE susceptibility.
    Fesel C, Coutinho A.
    J Autoimmun; 2000 Jun 01; 14(4):319-24. PubMed ID: 10882058
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
    Hilliard BA, Kamoun M, Ventura E, Rostami A.
    Exp Mol Pathol; 2000 Feb 01; 68(1):29-37. PubMed ID: 10640452
    [Abstract] [Full Text] [Related]

  • 12. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
    Matsumoto Y, Fujiwara M.
    Cell Immunol; 1993 Jul 01; 149(2):268-78. PubMed ID: 7687198
    [Abstract] [Full Text] [Related]

  • 13. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E, Wiegmann K, Wollmann R, Arnason BG, Kim DH.
    J Autoimmun; 1998 Aug 01; 11(4):329-34. PubMed ID: 9776710
    [Abstract] [Full Text] [Related]

  • 14. Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.
    Fritz RB, Chou CH, McFarlin DE.
    J Immunol; 1983 Mar 01; 130(3):1024-6. PubMed ID: 6185565
    [Abstract] [Full Text] [Related]

  • 15. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
    Javed NH, Gienapp IE, Cox KL, Whitacre CC.
    J Immunol; 1995 Aug 01; 155(3):1599-605. PubMed ID: 7543526
    [Abstract] [Full Text] [Related]

  • 16. Sequence determinants of modified cobra venom neurotoxin which induce immune resistance to experimental allergic encephalomyelitis: molecular mechanisms for immunologic action.
    Hinman CL, Stevens-Truss R, Schwarz C, Hudson RA.
    Immunopharmacol Immunotoxicol; 1999 Aug 01; 21(3):483-506. PubMed ID: 10466076
    [Abstract] [Full Text] [Related]

  • 17. Diversity of the B cell repertoire to myelin basic protein in rat strains susceptible and resistant to EAE.
    Figueiredo AC, Cohen IR, Mor F.
    J Autoimmun; 1999 Feb 01; 12(1):13-25. PubMed ID: 10028018
    [Abstract] [Full Text] [Related]

  • 18. Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice.
    Ben-Nun A, Lando Z.
    J Immunol; 1983 Mar 01; 130(3):1205-9. PubMed ID: 6185574
    [Abstract] [Full Text] [Related]

  • 19. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
    Ramírez F, Mason D.
    Eur J Immunol; 2000 Mar 01; 30(3):747-58. PubMed ID: 10741389
    [Abstract] [Full Text] [Related]

  • 20. Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Meyer AL, Benson JM, Gienapp IE, Cox KL, Whitacre CC.
    J Immunol; 1996 Nov 01; 157(9):4230-8. PubMed ID: 8892661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.